Sarepta Therapeutics
SRPT
#5003
Rank
โ‚ฌ1.70 B
Marketcap
16,14ย โ‚ฌ
Share price
-1.64%
Change (1 day)
0.63%
Change (1 year)
Sarepta Therapeutics is an American medical research company dedicated to the discovery and development of precisely effective gene therapeutics for the treatment of rare neuromuscular diseases.

Earnings for Sarepta Therapeutics (SRPT)

Earnings in 2026 (TTM): -โ‚ฌ0.11 Billion

According to Sarepta Therapeutics 's latest financial reports the company's current earnings are โ‚ฌ1.97 Billion. In 2025 the company made an earning of -โ‚ฌ0.62 Billion a decrease over its 2024 earnings that were of โ‚ฌ0.22 Billion. The earnings displayed on this page are the earnings before interest and taxes or simply EBIT.

Earnings history for Sarepta Therapeutics from 1997 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -โ‚ฌ0.11 Billion-82.64%
2025 -โ‚ฌ0.62 Billion-369.28%
2024 โ‚ฌ0.22 B-150.14%
2023 -โ‚ฌ0.46 Billion-24.62%
2022 -โ‚ฌ0.61 Billion64.69%
2021 -โ‚ฌ0.37 Billion-24.25%
2020 -โ‚ฌ0.49 Billion-22.53%
2019 -โ‚ฌ0.63 Billion96.87%
2018 -โ‚ฌ0.32 Billion645.68%
2017 -โ‚ฌ42.8 Million-81.81%
2016 -โ‚ฌ0.24 Billion21.47%
2015 -โ‚ฌ0.2 Billion62.04%
2014 -โ‚ฌ0.12 Billion21.26%
2013 -โ‚ฌ98.56 Million60.93%
2012 -โ‚ฌ61.25 Million93.69%
2011 -โ‚ฌ31.62 Million71.58%
2010 -โ‚ฌ18.43 Million35.06%
2009 -โ‚ฌ13.65 Million-11.62%
2008 -โ‚ฌ15.44 Million-47.02%
2007 -โ‚ฌ29.14 Million0.38%
2006 -โ‚ฌ29.03 Million88.3%
2005 -โ‚ฌ15.42 Million-30.06%
2004 -โ‚ฌ22.05 Million32.69%
2003 -โ‚ฌ16.62 Million-25.52%
2002 -โ‚ฌ22.31 Million64.52%
2001 -โ‚ฌ13.56 Million50.4%
2000 -โ‚ฌ9.02 Million26.44%
1999 -โ‚ฌ7.13 Million8%
1998 -โ‚ฌ6.61 Million102.7%
1997 -โ‚ฌ3.26 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Gilead Sciences
GILD
-โ‚ฌ1.73 Billion 1,393.28%๐Ÿ‡บ๐Ÿ‡ธ USA
PTC Therapeutics
PTCT
-โ‚ฌ59.04 Million-48.77%๐Ÿ‡บ๐Ÿ‡ธ USA
Novavax
NVAX
-โ‚ฌ0.2 Billion 70.65%๐Ÿ‡บ๐Ÿ‡ธ USA
Alnylam Pharmaceuticals
ALNY
โ‚ฌ0.98 B-959.03%๐Ÿ‡บ๐Ÿ‡ธ USA
Insmed
INSM
-โ‚ฌ0.7 Billion 505.94%๐Ÿ‡บ๐Ÿ‡ธ USA
BioCryst Pharmaceuticals
BCRX
-โ‚ฌ0.34 Billion 191.16%๐Ÿ‡บ๐Ÿ‡ธ USA
Avidity Biosciences
RNAM
-โ‚ฌ0.61 Billion 422.94%๐Ÿ‡บ๐Ÿ‡ธ USA